Caroline M. Loewy
A member of the Zogenix board of directors since September 2020, Ms. Loewy has more than 25 years of experience in the biopharmaceutical industry and currently serves as a strategic business and financial advisor to life science companies. She has held numerous executive roles throughout her career, most recently as co-founder, Chief Financial Officer, and Chief Business Officer of Achieve Life Sciences, Inc. Prior to Achieve Life Sciences, Ms. Loewy served as Chief Financial Officer of Tobira Therapeutics, Corcept Therapeutics and Poniard Pharmaceuticals. Earlier in her career, Ms. Loewy was Executive Director of Biotechnology Equity Research at Morgan Stanley and served as Managing Director of Biotechnology Equity Research at Prudential Securities. She began her career as a financial analyst at BankAmerica Corporation.
Ms. Loewy serves on the Boards of Directors of PhaseBio Pharmaceuticals, Aptose Biosciences and CymaBay Therapeutics. She is a founding board member of the Global Genes Project, a leading rare disease patient advocacy organization, a member of the Steering Committee of the Forum for Collaborative Research in Rare Diseases, and a co-founder of KCNQ2 Cure Alliance, a non-profit advancing research for the rare disease KCNQ2 epileptic encephalopathy. Ms. Loewy holds an M.B.A. and M.S. from Carnegie Mellon University and a B.A. from the University of California, Berkeley.